Wednesday, September 17, 2008

HIV Infections Among South Carolina Blacks Six Times Higher

The rate of new HIV infections among blacks in South Carolina was six times higher than among all other races combined in 2006, according to new estimates released Friday by the South Carolina Department of Health and Environmental Control, the Columbia State reports.

read more

Complete news at...

For the past decade, baby boomers have been well-educated about the severity of blood clots in the brain causing strokes. But what many of them still do not understand is the potentially fatal effects of blood clots in their legs and arms as well as their available treatment options. An innovative clot-removal procedure, highlighted in a recent study, yields a 94.7 percent success rate in preventing amputation. Complete news at...

The number of newly reported HIV cases in Alberta, Canada, increased by 29% in 2007 compared with 2005, the CP/Calgary Sun reports. Alberta recorded 225 new HIV cases in 2007, compared with 175 in 2005. Of those cases, 99 were recorded in Calgary, compared with 89 in Edmonton. According to the CP/Sun, Calgary has replaced Edmonton as the city in Alberta with the largest percentage of newly reported HIV cases: 43.8% compared with 39.8%, respectively.

read more

Complete news at...

There is a new and interesting way toprovide obesity treatment. An injection to certain blood vessels in stomach suppressed appetite hormone in pigs and may offer an easy way to fight obesity in humans.

Scientists from John Hopkins University School of Medicine examined 10 growing, young, healthy pigs. Researchers chose pigs for the obesity study because they have anatomy very similar to humans.

read more

Complete news at...

Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer.

read more

Complete news at...

An increasing percentage of teenagers in Malawi have taken an HIV test during the past two years, according to a Welfare Monitoring Survey recently released by the National Statistical Office, Malawi's Nation Reporter reports. According to the survey, the percentage of Malawians older than age 15 who have ever received an HIV test increased from 20% in 2006 to 34% in 2007.

read more

Complete news at...

Scientists have developed a breast cancer vaccine which turned to be an effective and safe means for even very aggressive types of breast cancer in a mice trial.

According to the American Cancer Society statistics, breast cancer is the most deadly one causing 1.3 million newly diagnosed and 465000 deaths cases a year worldwide. Patients with HER2 positive cancer account for 20-30% of all cancer sufferers. This type of cancer is very aggressive and drug resistant. The most common drug to fight breast cancer is Herceptin, but HER2 cancer mutates and gets used to the drug.

read more

Complete news at...

A "two-speed" HIV/AIDS epidemic is taking place in Australia, Jonathan Anderson, president of the Australasian Society for HIV Medicine, writes in an Australian opinion piece. Rates among men who have sex with men "have been rising in Australia since the start of the decade," Anderson writes, adding that at the "same time, infections in new populations -- such as Australian heterosexual men traveling overseas for sex -- have highlighted the need for more sophisticated and complex responses."

read more

Complete news at...

Tuesday, September 16, 2008

Nottingham Scientists Identify Childhood Brain Cancer Genes

Scientists at The University of Nottingham have isolated three important genes involved in the development of a type of childhood brain cancer. The breakthrough is revealed in a study published in the British Journal of Cancer. Read more ...

New research has highlighted stark disparities in access to the latest cancer drugs across European Union nations, according to data presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. While countries like France, Spain, Austria and Switzerland have tended to introduce the new drugs quickly, researchers say, others such as the UK and more recent EU entrants bring them in more slowly. Read more ...

An investigational drug that combats ovarian cancer by inhibiting the formation of new blood vessels has shown promise in a phase II trial, according to a presentation at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. Prof. Michael Friedlander from Australia presented the results of an international collaborative trial which administered the drug to 35 patients with recurrent ovarian, fallopian tube or peritoneal carcinoma. Read more ...

Physicians now have a powerful new tool with industry-leading technology to ablate soft tissue. The Interventional Oncology business unit of Covidien Ltd. (NYSE: COV, BSX: COV), the world leader in advanced energy-based surgical systems, today announced the global release of the Evident™ microwave ablation system. The Evident™ microwave ablation system is intended for coagulation of soft tissue during percutaneous, laparoscopic and open surgical procedures. Read more ...

For patients with chemotherapy-induced anemia, adding intravenous iron to treatment with the drug darbepoetin alfa results in a faster and more potent improvement in response with lower doses of the drug, according to data presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. Anemia is a common problem in cancer patients, caused by a combination of factors including the malignancy itself, plus the effects of chemotherapy. Read more ...

The investigational agent ipilimumab is showing promise as a therapy for both treatment-naïve and previously treated patients with late-stage melanoma, according to phase 2 results released here at the 33rd Congress of the European Society for Medical Oncology (ESMO). Read more ...

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the malignant melanoma drug market, driven by the launch of emerging agents, will experience robust annual 12 percent growth through 2012 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Read more ...

Drais Pharmaceuticals, Inc. and Unibioscreen S.A. announced that they have entered into a global agreement to develop and commercialize UNBS5162, one of Unibioscreen's investigational drug and potential breakthrough treatments for cancer. UNBS5162 was discovered by Unibioscreen and is currently in Phase I trials in the United States in cancer patients with advanced solid tumors or lymphoma. Read more ...

Treating Recurring Cold Sores

Suffering from chronic cold sores is a very annoying and embarrassing problem. It is caused by Herpes Simplex Virus Type 1 (HSV-1) and the virus is highly contagious. People will avoid you and it can ruin your social and personal life. A close contact with someone through kissing and oral sex can cause the virus to spread from one person to another. Once you have the virus, it could become a chronic problem and it is important to know the effective ways on treating recurring cold sores.